Advanced search
Publication Cover
Expert Review of Medical Devices Volume 13, 2016 - Issue 1
Submit an article Journal homepage
844
Views
26
CrossRef citations to date
0
Altmetric
Review

Moving toward the ideal insulin for insulin pumps

Eda CengizDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, USACorrespondence[email protected]
,
Bruce BodeAtlanta Diabetes Associates, Atlanta, GA, USA
,
Michelle Van NameDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, USA
&
William V TamborlaneYale Center for Clinical Investigation, Yale University School of Medicine, New Haven, CT, USA
Pages 57-69 | Published online: 11 Nov 2015

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eveline Lefever, Joke Vliebergh & Chantal Mathieu. (2021) Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions. Expert Opinion on Drug Safety 20:2, pages 155-169.
Read now
Lia Bally, Hood Thabit & Roman Hovorka. (2017) Finding the right route for insulin delivery – an overview of implantable pump therapy. Expert Opinion on Drug Delivery 14:9, pages 1103-1111.
Read now

Articles from other publishers (24)

Francesco Giorgino, Tadej Battelino, Richard M. Bergenstal, Thomas Forst, Jennifer B. Green, Chantal Mathieu, Helena W. Rodbard, Oliver Schnell & Emma G. Wilmot. (2023) The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of Diabetes Science and Technology.
Crossref
Clipper F. Young, Shirley M.T. Wong & Kees A. Vanderwyk. 2023. Biomedical Engineering of Pancreatic, Pulmonary, and Renal Systems, and Applications to Medicine. Biomedical Engineering of Pancreatic, Pulmonary, and Renal Systems, and Applications to Medicine 299 356 .
Eda Cengiz, Thomas Danne, Tariq Ahmad, Ahila Ayyavoo, David Beran, Sarah Ehtisham, Jan Fairchild, Przemyslawa Jarosz‐Chobot, Sze May Ng, Megan Paterson & Ethel Codner. (2022) ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes . Pediatric Diabetes 23:8, pages 1277-1296.
Crossref
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy & Reem Elbeltagi. (2022) Insulin pumps in children - a systematic review. World Journal of Clinical Pediatrics 11:6, pages 463-484.
Crossref
Patrícia Rosinha, Sofia Teixeira, Joana Vilaverde & Maria Helena Cardoso. (2022) Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?. Cureus.
Crossref
Christophe E. M. De Block, Jolijn Van Cauwenberghe, Niels Bochanen & Eveline Dirinck. (2022) Rapid‐acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes . Diabetes, Obesity and Metabolism.
Crossref
Richa Sharma, Dhirendra Singh, Prerna Gaur & Deepak Joshi. (2021) Intelligent automated drug administration and therapy: future of healthcare. Drug Delivery and Translational Research 11:5, pages 1878-1902.
Crossref
Marco Infante, David A. Baidal, Michael R. Rickels, Andrea Fabbri, Jay S. Skyler, Rodolfo Alejandro & Camillo Ricordi. (2021) Dual‐hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions. Artificial Organs 45:9, pages 968-986.
Crossref
Patricio Colmegna, Eda Cengiz, Jose Garcia-Tirado, Kristen Kraemer & Marc D. Breton. (2020) Impact of Accelerating Insulin on an Artificial Pancreas System Without Meal Announcement: An In Silico Examination. Journal of Diabetes Science and Technology 15:4, pages 833-841.
Crossref
Hanne Haahr & Tim Heise. (2020) Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences. Diabetes mellitus 23:2, pages 140-160.
Crossref
Eda Cengiz. (2020) Automated Insulin Delivery in Children with Type 1 Diabetes. Endocrinology and Metabolism Clinics of North America 49:1, pages 157-166.
Crossref
Hanne Haahr & Tim Heise. (2019) Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences. Clinical Pharmacokinetics 59:2, pages 155-172.
Crossref
Sanjun Shi, Na Kong, Chan Feng, Aram Shajii, Claire Bejgrowicz, Wei Tao & Omid C. Farokhzad. (2019) Drug Delivery Strategies for the Treatment of Metabolic Diseases. Advanced Healthcare Materials 8:12, pages 1801655.
Crossref
Ronald J. Pettis, Douglas Muchmore & Lutz Heinemann. (2018) Subcutaneous Insulin Administration: Sufficient Progress or Ongoing Need?. Journal of Diabetes Science and Technology 13:1, pages 3-7.
Crossref
Ana Catarina Silva, Cládia Pina Costa, Hugo Almeida, João Nuno Moreira & José Manuel Sousa Lobo. 2020. Current Applications of Pharmaceutical Biotechnology. Current Applications of Pharmaceutical Biotechnology 115 153 .
Angela McGibbon, Lenley Adams, Karen Ingersoll, Tina Kader & Barna Tugwell. (2018) Glycemic Management in Adults With Type 1 Diabetes. Canadian Journal of Diabetes 42, pages S80-S87.
Crossref
Thomas DanneLutz HeinemannJan Bolinder. (2018) New Insulins, Biosimilars, and Insulin Therapy. Diabetes Technology & Therapeutics 20:S1, pages S-55-S-70.
Crossref
Eric Zijlstra, Marek Demissie, Tina Graungaard, Tim Heise, Leszek Nosek & Bruce Bode. (2017) Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes. Journal of Diabetes Science and Technology 12:1, pages 145-151.
Crossref
Alfonso Galderisi, Elise Schlissel & Eda Cengiz. (2017) Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes. Current Diabetes Reports 17:11.
Crossref
Torben Biester, Olga Kordonouri & Thomas Danne. (2017) Pharmacological Properties of Faster-Acting Insulin Aspart. Current Diabetes Reports 17:11.
Crossref
Mingqi Xie, Dominique Aubel & Martin Fussenegger. (2017) Closed-loop control systems – The quest for precision therapies for diabetes. Current Opinion in Systems Biology 5, pages 32-40.
Crossref
Chantal Mathieu, Pieter Gillard & Katrien Benhalima. (2017) Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nature Reviews Endocrinology 13:7, pages 385-399.
Crossref
Tim Heise, Eric Zijlstra, Leszek Nosek, Tord Rikte & Hanne Haahr. (2017) Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial. Diabetes, Obesity and Metabolism 19:2, pages 208-215.
Crossref
Thomas DanneLutz HeinemannJan Bolinder. (2017) New Insulins, Biosimilars, and Insulin Therapy. Diabetes Technology & Therapeutics 19:S1, pages S-42-S-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.